Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
Links shared publicly online about this topic.
- 785total visits
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
fda.gov —
Prolonged QT or PR intervals reported when Invirase is used with the antiviral medication, Norvir (ritonavir).
View full resource at fda.gov
Tags: Heart, HIV Medication, Drug, FDA, Norvir, Invirase
Most Recently Shared on October 21, 2010 at 7:58 pm By:
Getting the word out: FDA: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm (http://bit.ly/9sMymg)
Advertisement
